A premier research institution providing global genomic profiling and molecular diagnostics services to academic centers, pharmaceutical and biotech industry, oncologists, and pathologists with innovative diagnostic, prognostic, predictive, and personalized testing.


Clinical Services
Research Services
Bioinformatics Services

Select Services

3 min read bioinformatics, microarray, ngs, advanced

We have the SOLUTIONS to meet your BIOINFORMATICS needs When it comes to developing custom pipelines, implementing the most cutting edge analyses & profiling techniques, we work with our clients to ensure their informatics needs are met. Whether implementing a sofisticated analysis method, designing a custom analysis pipeline, utilizing cutting-edge machine learning techniques for biomarker classification, or simply producing publication-ready figures, our staff combines years of experience with highly qualified personnel to meet your every need.

CONTINUE READING

1 min read services, ngs, microarray, expression, research

Gene Expression Services Scientists at Genome Explorations have worked with over 350 scientists worldwide in meeting their gene expression needs. As an industry leader in the microarray field and a certified provider of Affymetrix® microarray services and Life Technologies qPCR services, we have developed a series of SOPs that allow us to reproducibly generate global gene expression data sets of the highest quality. Our validated microarray protocols consistently result in sample-to-sample variability of less than 0.

CONTINUE READING

10 min read services, ngs, cancer, clinical, breast, lung, liver, colorectal, leukemia, ovarian, prostate, gastric, cancer-specific

Detect, Characterize. Genomic research continues to identify mutations associated with specific cancers and, in combination with clinical research, to identify their clinical relevance to a specific cancer and the prognosis/treatment for patients. While some mutations may be pathogenic, some are benign. Mutation profiling allows us to identify which mutations are present, determine clinical significance of those mutations, and identify pathogentic mutations with actionable therapies. To this end, mutation profiling using next generation sequencing and targeted cancer-specific panels allows us to detect mutations across multiple genes simultaneously and to screen patient susceptibility to a specific cancer.

CONTINUE READING

Contact